Evidence-based analysis of risk factors for sudden cardiac death

Heart Rhythm

Volumn 6, Issue 3 SUPPL., 2009, Pages

  Goldberger, Jeffrey J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Risk stratification; Sudden cardiac death

Indexed keywords

ARTICLE; CLINICAL DECISION MAKING; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; EVIDENCE BASED MEDICINE; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PATIENT IDENTIFICATION; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SUDDEN DEATH;

DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EVIDENCE-BASED MEDICINE; HUMANS; RISK ASSESSMENT; RISK FACTORS;

EID: 61849154055     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2008.11.007     Document Type: Article

References (30)

1. Pratt C.M., Greenway P.S., Schoenfeld M.H., et al. Exploration of the precision of classifying sudden cardiac death: implications for the interpretation of clinical trials. Circulation 93 (1996) 519-524
2. Pires L.A., Lehmann M.H., Steinman R.T., et al. Sudden death in implantable cardioverter-defibrillator recipients: clinical context, arrhythmic events and device responses. J Am Coll Cardiol 33 (1999) 24-32
3. Grubman E.M., Pavri B.B., Shipman T., et al. Cardiac death and stored electrograms in patients with third-generation implantable cardioverter-defibrillators. J Am Coll Cardiol 32 (1998) 1056-1062
4. Zipes D.P., and Roberts D. Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators. Circulation 92 (1995) 59-65
5. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335 (1996) 1933-1940
6. Huikuri H.V., Tapanainen J.M., Lindgren K., et al. Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. J Am Coll Cardiol 42 (2003) 652-658
7. Goldberger J., Cain M., Hohnloser S., et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Circulation 118 (2008) 1497-1518
8. The Cardiac Arrhythmia Suppression Trial (CAST) investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321 (1989) 406-112
9. Hull Jr. S.S., Vanoli E., Adamson P.B., et al. Do increases in markers of vagal activity imply protection from sudden death?. The case of scopolamine. Circulation 91 (1995) 2516-2519
10. Jouven X., Empana J.P., Schwartz P.J., et al. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med 352 (2005) 1951-1958
11. Kaikkonen K.S., Kortelainen M.L., Linna E., et al. Family history and the risk of sudden cardiac death as a manifestation of an acute coronary event. Circulation 114 (2006) 1462-1467
12. The Multicenter Post-Infarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 309 (1983) 331-336
13. Stecker E.C., Vickers C., Waltz J., et al. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol 47 (2006) 1161-1166
14. Goldenberg I., Vyas A.K., Hall W.J., et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 51 (2008) 288-296
15. Buxton A.E., Lee K.L., Hafley G.E., et al. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. J Am Coll Cardiol 50 (2007) 1150-1157
16. Robin J., Weinberg K., Tiongson J., et al. Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients. Heart Rhythm 3 (2006) 1196-1201
17. Zipes D.P., Camm A.J., Borggrefe M., et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol 48 (2006) e247-e346
18. Available at: http://www.cms.hhs.gov/mcd/viewncd.asp?ncd_id=20.4&ncd_version= 3&basket=ncd%3A20%2E4%3A3%3AImplantable+Automatic+Defibrillators.
19. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
20. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
21. Hohnloser S.H., Kuck K.H., Dorian P., et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 351 (2004) 2481-2488
22. Wilber D.J., Zareba W., Hall W.J., et al. Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation 109 (2004) 1082-1084
23. Solomon S.D., Zelenkofske S., McMurray J.J., et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 352 (2005) 2581-2588
24. Pitt B., White H., Nicolau J., et al. Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure. J Am Coll Cardiol 46 (2005) 425-431
25. Cook N.R. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115 (2007) 928-935
26. Pepe M.S., Janes H., Longton G., et al. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 159 (2004) 882-890
27. Bailey J.J., Berson A.S., Handelsman H., et al. Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction. J Am Coll Cardiol 38 (2001) 1902-1911
28. Buxton A.E., Lee K.L., Fisher J.D., et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 341 (1999) 1882-1890
29. Costantini O., Hohnloser S., Kirk M., et al. The alternans before cardioverter defibrillator trial: strategies using T wave alternans to improve efficiency of sudden cardiac death prevention. J Am Coll Cardiol (2008) in press
30. Bigger Jr. J.T., and Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery. N Engl J Med 337 (1997) 1569-1575